rs13218331

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_019111.5(HLA-DRA):​c.610+119A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.141 in 1,142,124 control chromosomes in the GnomAD database, including 12,656 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.13 ( 1432 hom., cov: 32)
Exomes 𝑓: 0.14 ( 11224 hom. )

Consequence

HLA-DRA
NM_019111.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.0620

Publications

14 publications found
Variant links:
Genes affected
HLA-DRA (HGNC:4947): (major histocompatibility complex, class II, DR alpha) HLA-DRA is one of the HLA class II alpha chain paralogues. This class II molecule is a heterodimer consisting of an alpha and a beta chain, both anchored in the membrane. This molecule is expressed on the surface of various antigen presenting cells such as B lymphocytes, dendritic cells, and monocytes/macrophages, and plays a central role in the immune system and response by presenting peptides derived from extracellular proteins, in particular, pathogen-derived peptides to T cells. The alpha chain is approximately 33-35 kDa and its gene contains 5 exons. Exon 1 encodes the leader peptide, exons 2 and 3 encode the two extracellular domains, and exon 4 encodes the transmembrane domain and the cytoplasmic tail. DRA does not have polymorphisms in the peptide binding part and acts as the sole alpha chain for DRB1, DRB3, DRB4 and DRB5. [provided by RefSeq, Aug 2020]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.146 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HLA-DRANM_019111.5 linkc.610+119A>C intron_variant Intron 3 of 4 ENST00000395388.7 NP_061984.2 P01903A0A0G2JMH6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HLA-DRAENST00000395388.7 linkc.610+119A>C intron_variant Intron 3 of 4 6 NM_019111.5 ENSP00000378786.2 P01903
HLA-DRAENST00000374982.5 linkc.535+119A>C intron_variant Intron 3 of 4 6 ENSP00000364121.5 Q30118
ENSG00000299747ENST00000766007.1 linkn.163-5325T>G intron_variant Intron 1 of 2

Frequencies

GnomAD3 genomes
AF:
0.127
AC:
19324
AN:
152082
Hom.:
1432
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0849
Gnomad AMI
AF:
0.391
Gnomad AMR
AF:
0.108
Gnomad ASJ
AF:
0.0616
Gnomad EAS
AF:
0.0423
Gnomad SAS
AF:
0.140
Gnomad FIN
AF:
0.220
Gnomad MID
AF:
0.0601
Gnomad NFE
AF:
0.148
Gnomad OTH
AF:
0.125
GnomAD4 exome
AF:
0.144
AC:
142097
AN:
989924
Hom.:
11224
Cov.:
13
AF XY:
0.142
AC XY:
71140
AN XY:
499274
show subpopulations
African (AFR)
AF:
0.0848
AC:
1949
AN:
22980
American (AMR)
AF:
0.0796
AC:
2398
AN:
30144
Ashkenazi Jewish (ASJ)
AF:
0.0556
AC:
991
AN:
17826
East Asian (EAS)
AF:
0.0529
AC:
1957
AN:
37012
South Asian (SAS)
AF:
0.135
AC:
8404
AN:
62210
European-Finnish (FIN)
AF:
0.214
AC:
10394
AN:
48578
Middle Eastern (MID)
AF:
0.0684
AC:
313
AN:
4576
European-Non Finnish (NFE)
AF:
0.152
AC:
109911
AN:
722908
Other (OTH)
AF:
0.132
AC:
5780
AN:
43690
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
6603
13207
19810
26414
33017
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3358
6716
10074
13432
16790
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.127
AC:
19340
AN:
152200
Hom.:
1432
Cov.:
32
AF XY:
0.130
AC XY:
9706
AN XY:
74410
show subpopulations
African (AFR)
AF:
0.0850
AC:
3528
AN:
41520
American (AMR)
AF:
0.108
AC:
1645
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.0616
AC:
214
AN:
3472
East Asian (EAS)
AF:
0.0422
AC:
218
AN:
5170
South Asian (SAS)
AF:
0.141
AC:
681
AN:
4820
European-Finnish (FIN)
AF:
0.220
AC:
2331
AN:
10602
Middle Eastern (MID)
AF:
0.0578
AC:
17
AN:
294
European-Non Finnish (NFE)
AF:
0.148
AC:
10089
AN:
68004
Other (OTH)
AF:
0.123
AC:
260
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
854
1708
2563
3417
4271
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
210
420
630
840
1050
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.122
Hom.:
1034
Bravo
AF:
0.116
Asia WGS
AF:
0.0970
AC:
341
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
0.62
DANN
Benign
0.35
PhyloP100
-0.062
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs13218331; hg19: chr6-32411362; COSMIC: COSV107495290; API